Acquired and Primary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
博士 === 國立臺灣大學 === 臨床醫學研究所 === 105 === Introduction: Precision medicine plays an important role for lung cancer treatment. The epidermal growth factor receptor (EGFR) mutation positive patients of lung adenocarcinoma had favored response to EGFR tyrosine kinase inhibitors (TKIs). However, acquired dr...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2016
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/g4y8h2 |